Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III RCT of NaPPS in Knee Osteoarthritis
jRCT2031250145Phase 3Recruiting
- Sponsor
- ReqMed Company, Ltd.
- Start
- Jun 2025
- Modality
- Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in knee osteoarthritis (OA) comparing NaPPS with Placebo (2 arms). Primary endpoint: Primary: Change in WOMAC-A pain score at Week 8. Started Jun 2025; status: recruiting.
02
Drugs
pentosan polysulfate sodium
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on jRCT2031250145.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2031250145.